21 May 2013
Keywords: Neglected diseases, R&D funding, Government action, G-FINDER
Article | 03 December 2012
A five-year review of global neglected disease R&D funding shows that, despite increased investment of almost half a ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
3 December 2012
20 May 2013
© 2013 thepharmaletter.com